• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌原发性及肺转移病灶中促纤维增生性反应与肿瘤芽生的关系及其预后意义

Relationship of Desmoplastic Reaction and Tumour Budding in Primary and Lung Metastatic Lesions of Colorectal Cancer and Their Prognostic Significance.

作者信息

Kobayashi Toshinori, Ishida Mitsuaki, Matsui Hiroshi, Uehara Hiroki, I Shoichiro, Yamada Norikazu, Igarashi Yuto, Hagiwara Chie, Mori Yoshihiro, Taniguchi Yohei, Saito Tomohito, Hino Haruaki, Hirose Yoshinobu, Murakawa Tomohiro, Watanabe Jun

机构信息

Department of Colorectal Surgery, Kansai Medical University, 2-5-1, Shinmachi, Hirakata 573-1010, Japan.

Department of Pathology, Osaka Medical and Pharmaceutical University, 2-7, Daigaku-machi, Takatsuki 569-8686, Japan.

出版信息

Cancers (Basel). 2025 Feb 8;17(4):583. doi: 10.3390/cancers17040583.

DOI:10.3390/cancers17040583
PMID:40002175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11852406/
Abstract

Histopathological indicators, including desmoplastic reaction (DR) and tumour budding (TB), are significant prognostic indicators for metastatic liver lesions in patients with colorectal cancer (CRC). However, the relationship of DR and TB in primary CRC and metastatic lung lesions and their prognostic significance has not yet been examined. This study aimed to elucidate the association of DR and TB in primary CRC and metastatic lung lesions. Patients with pT3 or pT4 CRC with lung metastasis who underwent surgical resection of the primary CRC and synchronous or metachronous metastatic lung lesions were enrolled. DR was classified into immature (IM) and non-IM types, and TB was classified into TB1 (<4 buds), TB2 (5-9 buds) and TB3 (≥10 buds) in both the primary CRC and metastatic lung lesions. Overall, 40 patients with CRC (males, 21; females, 19; median age, 70 years; right-side colon, 6; left-side colon, 9; rectum, 25; pT3, 31; pT4, 9) were evaluated. Six and thirty-four patients were classified as having IM and non-IM DR in the metastatic lung lesions, respectively. Thirty-one, seven, and two patients were classified as having TB1, TB2, and TB3, respectively. There was no significant correlation between primary and lung metastatic lesions for DR ( = 0.08, = 0.086), whereas TB demonstrated a moderate correlation ( = 0.47, = 0.015). The presence of IM DR and TB2/3 in metastatic lung lesions significantly correlated with poor overall survival ( = 0.0020 and 0.044, respectively). histological indicators of metastatic lung lesions in CRC may provide important prognostic information for better patient care.

摘要

组织病理学指标,包括促纤维增生性反应(DR)和肿瘤芽生(TB),是结直肠癌(CRC)患者肝转移灶的重要预后指标。然而,原发性结直肠癌和肺转移灶中DR与TB的关系及其预后意义尚未得到研究。本研究旨在阐明原发性结直肠癌和肺转移灶中DR与TB的关联。纳入接受原发性结直肠癌手术切除及同期或异时性肺转移灶切除的pT3或pT4期伴有肺转移的CRC患者。在原发性结直肠癌和肺转移灶中,DR分为未成熟(IM)型和非IM型,TB分为TB1(<4个芽)、TB2(5 - 9个芽)和TB3(≥10个芽)。总共评估了40例CRC患者(男性21例,女性19例;中位年龄70岁;右半结肠6例,左半结肠9例,直肠25例;pT3 31例,pT4 9例)。肺转移灶中分别有6例和34例患者被分类为IM DR和非IM DR。分别有31例、7例和2例患者被分类为TB1、TB2和TB3。原发性和肺转移灶之间的DR无显著相关性( = 0.08, = 0.086),而TB表现出中度相关性( = 0.47, = 0.015)。肺转移灶中IM DR和TB2/3的存在与较差的总生存期显著相关(分别为 = 0.0020和0.044)。CRC肺转移灶的组织学指标可为更好地护理患者提供重要的预后信息。

相似文献

1
Relationship of Desmoplastic Reaction and Tumour Budding in Primary and Lung Metastatic Lesions of Colorectal Cancer and Their Prognostic Significance.结直肠癌原发性及肺转移病灶中促纤维增生性反应与肿瘤芽生的关系及其预后意义
Cancers (Basel). 2025 Feb 8;17(4):583. doi: 10.3390/cancers17040583.
2
Significance of desmoplastic reactions on tumor deposits in patients with colorectal cancer.促纤维增生反应在结直肠癌患者肿瘤沉积物中的意义。
Oncol Lett. 2022 Nov 8;25(1):1. doi: 10.3892/ol.2022.13587. eCollection 2023 Jan.
3
Intraepithelial tumour infiltrating lymphocytes are associated with absence of tumour budding and immature/myxoid desmoplastic reaction, and with better recurrence-free survival in stages I-III colorectal cancer.肿瘤上皮内浸润淋巴细胞与肿瘤芽缺失、不成熟/黏液样促结缔组织反应以及Ⅰ-Ⅲ期结直肠癌无复发生存率的提高有关。
Histopathology. 2021 Jan;78(2):252-264. doi: 10.1111/his.14211. Epub 2020 Sep 14.
4
Prognostic scoring system based on indicators reflecting the tumor glandular differentiation and microenvironment for patients with colorectal cancer.基于反映结直肠癌肿瘤腺分化和微环境指标的预后评分系统。
Sci Rep. 2024 Jun 20;14(1):14188. doi: 10.1038/s41598-024-65015-2.
5
Morphological consistency of desmoplastic reactions between the primary colorectal cancer lesion and associated metastatic lesions.原发结直肠癌病灶与其相关转移病灶间促纤维结缔组织增生反应的形态学一致性。
Virchows Arch. 2020 Jul;477(1):47-55. doi: 10.1007/s00428-019-02742-2. Epub 2020 Jan 13.
6
Tumour budding - an additional prognostic factor in colorectal cancer survival.肿瘤芽生——结直肠癌生存的另一个预后因素。
Pol J Pathol. 2023;74(1):36-41. doi: 10.5114/pjp.2023.127040.
7
The relationship between primary colorectal cancer histology and the histopathological growth patterns of corresponding liver metastases.原发性结直肠癌组织学与相应肝转移的组织病理学生长模式之间的关系。
BMC Cancer. 2022 Aug 22;22(1):911. doi: 10.1186/s12885-022-09994-3.
8
Clinical features and prognostic factors of brain metastases from colorectal cancer: a single center experience.结直肠癌脑转移的临床特征和预后因素:单中心经验。
Int J Colorectal Dis. 2023 Jul 19;38(1):198. doi: 10.1007/s00384-023-04451-4.
9
Prognostic significance of histological categorization of desmoplastic reaction in colorectal liver metastases.结直肠肝转移中促结缔组织增生反应的组织学分类的预后意义。
Virchows Arch. 2019 Sep;475(3):341-348. doi: 10.1007/s00428-019-02580-2. Epub 2019 May 10.
10
Development and Validation of a Novel Prognostic Nomogram Combined With Desmoplastic Reaction for Synchronous Colorectal Peritoneal Metastasis.一种结合促纤维增生性反应的新型同步结直肠癌腹膜转移预后列线图的开发与验证
Front Oncol. 2022 Mar 11;12:826830. doi: 10.3389/fonc.2022.826830. eCollection 2022.

本文引用的文献

1
Quantifying Tumor Budding: Implications for Prognosis in Gastric Adenocarcinoma.肿瘤芽生的量化:对胃腺癌预后的影响
Am J Surg Pathol. 2025 Apr 1;49(4):363-371. doi: 10.1097/PAS.0000000000002360. Epub 2025 Jan 14.
2
Prognostic scoring system based on indicators reflecting the tumor glandular differentiation and microenvironment for patients with colorectal cancer.基于反映结直肠癌肿瘤腺分化和微环境指标的预后评分系统。
Sci Rep. 2024 Jun 20;14(1):14188. doi: 10.1038/s41598-024-65015-2.
3
Tumour budding as a risk factor for lymph node metastases in cutaneous squamous cell carcinoma: a systematic review and meta-analysis.
肿瘤芽作为皮肤鳞状细胞癌淋巴结转移风险因素:系统评价和荟萃分析。
Clin Exp Dermatol. 2024 Oct 24;49(11):1301-1308. doi: 10.1093/ced/llae155.
4
Prognostic significance of tumour budding in noncolorectal gastrointestinal tract and pancreatobiliary tract: a systematic review and meta-analysis.肿瘤芽在非结直肠胃肠道和胰胆系统中的预后意义:系统评价和荟萃分析。
Histopathology. 2024 Jun;84(7):1079-1091. doi: 10.1111/his.15154. Epub 2024 Feb 16.
5
Pulmonary Metastasis as the First Site of Metastasis After Curative Surgery for Colon Cancer: Incidence and Risk Factors According to the TNM Stage.结直肠癌根治术后肺部转移为首发转移灶:基于 TNM 分期的发生率及危险因素。
Dis Colon Rectum. 2024 Apr 1;67(4):523-530. doi: 10.1097/DCR.0000000000003036. Epub 2023 Dec 26.
6
Prognostic Value of Tumor Budding in Urothelial Carcinoma: A Meta-Analysis and Systematic Review.肿瘤芽在尿路上皮癌中的预后价值:荟萃分析和系统评价。
Lab Invest. 2023 Jun;103(6):100136. doi: 10.1016/j.labinv.2023.100136. Epub 2023 Mar 27.
7
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth.不断演变的肿瘤微环境:从癌症起始到转移灶生长
Cancer Cell. 2023 Mar 13;41(3):374-403. doi: 10.1016/j.ccell.2023.02.016.
8
The prognostic role of tumor budding and tumor-stroma ratio in pulmonary metastasis of colorectal carcinoma.肿瘤芽殖和肿瘤间质比在结直肠癌肺转移中的预后作用。
Eur J Surg Oncol. 2023 Jul;49(7):1298-1306. doi: 10.1016/j.ejso.2023.02.009. Epub 2023 Feb 21.
9
Tumor budding may be a promising prognostic indicator in intrahepatic cholangiocarcinoma: A multicenter retrospective study.肿瘤芽生可能是肝内胆管癌一个有前景的预后指标:一项多中心回顾性研究。
Ann Gastroenterol Surg. 2022 Jul 30;7(1):138-146. doi: 10.1002/ags3.12605. eCollection 2023 Jan.
10
Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN.2020年和2040年全球结直肠癌负担:来自全球癌症负担(GLOBOCAN)的发病率和死亡率估计
Gut. 2023 Feb;72(2):338-344. doi: 10.1136/gutjnl-2022-327736. Epub 2022 Sep 8.